Immune Checkpoint Inhibitor-induced Thyroid Dysfunction Is Associated with Higher Body Mass Index
Author(s) -
Rena Pollack,
Amit Ashash,
Avivit Cahn,
Yakir Rottenberg,
Hagay Stern,
Rivka Dresner–Pollak
Publication year - 2020
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/clinem/dgaa458
Subject(s) - medicine , body mass index , immune system , immune checkpoint , thyroid dysfunction , thyroid , index (typography) , oncology , immunology , immunotherapy , computer science , world wide web
Obesity is a proinflammatory metabolic state that may play a role in the development of immune-related adverse events (irAEs) associated with immune checkpoint inhibitor therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom